HMGB1 and Schnyder corneal dystrophy: Withstanding the small sample size, the data we have generated suggests that the relationship between HMGB1, SCD, and PD-L1 may help clinicians stratify patients into groups based on the potential to predict the immunological sensitivity of tumors to current and future immunotherapies.